Involvement of renin-angiotensin system and vasoactive angiotensin-(1-7) metabolite of angiotensin ii in gastric mucosal injury and gastroprotection

Frontiers of Gastrointestinal Research

Volumn 30, Issue , 2012, Pages 181-190

  Brzozowski, Tomasz ^a   Kwiecien, Slawomir ^a   Szlachcic, Aleksandra ^a   Strzalka, Malgorzata ^a   Drozdowicz, Danuta ^a   Pajdo, Robert ^a   Szmyd, Jakub ^a   Konturek, Stanislaw J ^a   Pawlik, Wieslaw W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALLERGEN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG METABOLITE; ENKEPHALINASE INHIBITOR; PERINDOPRILAT; RAS PROTEIN; TIORPHAN; UNCLASSIFIED DRUG;

COLD STRESS; CONFERENCE PAPER; DIGESTIVE FUNCTION; DRUG EFFICACY; DRUG METABOLISM; GASTROINTESTINAL DISEASE; MAS GENE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; STOMACH BLOOD FLOW; STOMACH MUCOSA INJURY; STOMACH PROTECTION; STRESS; ULCER HEALING; VASODILATATION;

EID: 84863734719     PISSN: 03020665     EISSN: 16623754     Source Type: Book Series    
DOI: 10.1159/000338442     Document Type: Conference Paper

References (39)

1. Tigerstedt R, Bergman PG: Niere und Kreislauf. Scand Arch Physiol 1898;4:223-271.
2. Skrbic R, Igic R: Seven decades of angiotensin (1939-2009). Peptides 2009;30:1945-1950.
3. Griendling KK, Lassgue B, Alexander RW: Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996;36:281-306.
4. Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86:747-803.
5. Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system -an endocrine and paracrine system. Endocrinology 2003;144:6:2179-2183.
6. Deshayes F, Nahmias C: Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005;16:293-299.
7. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM: Upregulation of angiotensin converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 2004;43:970-976.
8. Kaparianos A, Argyropoulou E: Local reninangiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome. Curr Med Chem 2011;18:3506-3515.
9. Lee MA, Bohm M, Paul M, Ganten D: Tissue renin angiotensin systems. Their role in cardiovascular disease. Circulation 1993;87:13.
10. Sechi LA, Valentin JP, Griffin CA, Schambelan M: Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine. Am J Physiol Gastrointest Liver Physiol 1993;265:G21-G27.
11. Bregonzio C, Armando I, Ando H, et al: Antiinflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 2003;285: G414.
12. Nakagiri A, Sunamoto M, Murakami M: Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats. Inflammopharmacology 2007;15:171-174.
13. Okuda T, Yoshida N, Takagi T, Handa O, Kokura S, Ichikawa H, Naito Y, Yoshikawa T: CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis. Dig Dis Sci 2008;53:657-663.
14. Riaz AA, Wang Y, Schramm R, et al: Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J 2004;18:881.
15. Takagi T, Yoshida N, Isozaki Y, et al: CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats. Eur J Pharmacol 2006;535:283.
16. Kwiecien S, Pawlik MW, Sliwowski Z, Kwiecien N, Brzozowski T, Pawlik WW, Konturek SJ: Involvement of sensory afferent fibers and lipid peroxidation in the pathogenesis of stress induced gastric mucosa damage. J Physiol Pharmacol 2007;58(suppl 3):149-162.
17. Brzozowski T, Konturek PC, Pajdo R, et al: Physiological mediators in nonsteroidal antiinflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins. J Physiol Pharmacol 2008;592:89.
18. Senay CE, Levine RJ: Synergism between cold and restraint for rapid production of stress ulcer in rats. Proc Soc Exp Biol Med 1967;124:1221-1223.
19. Jezova D, Ochedalski T, Kiss A, Aguilera G: Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol 1998;10:67-72.
20. Ruiz-Ortega M, Lorenzo O, Suzuki Y, et al: Proinflammatory actions of angiotensins. Cur Opin Nephrol Hypertens 2001;10:321.
21. Heinemann A, Sattler V, Jocic M, Wienen W, Holzer P: Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on gastric mucosal blood flow. Aliment Pharmacol Ther 1999;13:347-355.
22. Zhang YM, Wei EQ, Hu X, et al: The role of nuclear factor-?B in the effect of angiotensin II in the paraventricular nucleus in protecting the gastric mucosa from ischemia-reperfusion injury in rats. J Gastroenterol 2008;43:687.
23. Gemici B, Tan R, Ongut G, Izgut-Uysal N: Expressions of inducible nitric oxide synthase and cyclooxygenase -2 in gastric ischemia -reperfusion: role of angiotensin II. J Surg Res 2009;6:1-8.
24. Ito T, Yamakawa H, Bregonzio C, Terron JA, Falcon-Neri, A, Saavedra JM: Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 2002;33: 2297-2303.
25. Carl-McGrath S, Grantzdorffer I, Lendeckel U, Ebert MP, Rocken C: Angiotensin II-generating enzymes, angiotensin-converting enzyme (ACE) and mast cell chymase (CMA1), in gastric inflammation may be regulated by H. pylori and associated cytokines. Pathology 2009;41:419-427.
26. Hasegawa G, Fukui M, Hosada H, Asano M, Harusato I, Tanaka M, Shiraishi E, Senmaru T, Sakabe K, Yamasaki M, Kitawaki J, Fujinami A, Ohta M, Obayashi H, Nakamura N: Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male spontaneously diabetic Torii rats. Eur J Pharmacol 2009;605:164-169.
27. Nakagiri A, Sunamoto M, Takeuchi K, Murakami M: Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angiotensin II. J Physiol Pharmacol 2010; 61:171-179.
28. Morsy MA, Ashour OM, Fouad AA, Abdel-Gaber SA: Gastroprotective effects of the insulin sensitizers, rosiglitazone and metformin, in indomethacininduced gastric ulcer in type 2 diabetic rats. Clin Exp Pharmacol Physiol 2010;37:173-177.
29. Brzozowski T, Ptak-Belowska A, Kwiecien S, Krzysiek-Maczka G, Strzalka M, Drozdowicz D, Pajdo R, Olszanecki R, Korbut R, Konturek SJ, Pawlik WW: Novel concept in the mechanism of injury and protection of gastric mucosa: role of renin-angiotensin system and active metabolites of angiotensin. Curr Med Chem 2012;19:55-62.
30. Hallersund P, Helander HF, Casselbrant A, Edebo A, Fandriks L, Elfvin A: Angiotensin II receptor expression and relation to Helicobacter pyloriinfection in the stomach of the Mongolian gerbil. BMC Gastroenterol 2010;10:3.
31. Huang W, Yu LF, Zhong J, et al: Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells. Dig Dis Sci 2009;54:2056-2062.
32. Soares de Moura R, Resende AC, Emiliano AF, et al: The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br J Pharmacol 2004;141:860-866.
33. Meng W, Busija DW: Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pail arterioles. Stroke 1993;24:2041-2044.
34. Ren Y, Garvin JL, Carretero OA: The vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 2002;39:799-802.
35. Kramkowski K, Mogielnicki A, Buczko W: The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 2006;57:529-539.
36. Olszanecki R, Madej J, Suski M, Gebska A, Bujak-Gizycka B, Korbut R: Angiotensin metabolism in rat stomach wall: prevalence of angiotensin-(1-7) formation. J Physiol Pharmacol 2009;60:191-196.
37. Bujak-Gizycka B, Madej J, Wolkow PP, Olszanecki R, Drabik L, Rutowski J, et al: Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS). J Physiol Pharmacol 2007;58:529-540.
38. Olszanecki R, Bujak-Gizycka B, Madej J, et al: Kaempferol, but not resveratrol inhibits angiotensin converting enzyme. J Physiol Pharmacol 2008;59: 387-392.
39. Haulica I, Bild W, Serban DN: Angiotensin peptides and their pleiotropic actions. J Renin Angiotensin Aldosterone Syst 2005;6:121-131.